TP-271

N/A

Report date: 2025/03/17 15:02:17
NMEQIDP

Base Information

Drug NameTP-271
Drug Alias NameTP-271
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of Action30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsPneumoniaBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTetraphase Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTetraphase Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPneumoniaBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A